|
WO2021069508A1
|
|
Antibodies having specificity for nectin-4 and uses thereof
|
|
WO2021063865A1
|
|
Devices and methods for the characterization of the 3d orientation of light emitting dipoles
|
|
WO2020178267A1
|
|
Nox inhibitors for preventing epileptic seizures
|
|
FR3102242A1
|
|
SENSOR WITH VARIATION OF IMPEDANCE OR INDUCTANCE CONSECUTIVE TO A VARIATION OF A MEASURAND
|
|
FR3099475A1
|
|
Multilayer coating for glazing, method of producing such a coating and glazing provided with said coating
|
|
FR3099293A1
|
|
One-piece semiconductor material particle detection device
|
|
EP3754663A1
|
|
Method and system for dating blood pools
|
|
EP3693139A1
|
|
Optical tactile sensor
|
|
WO2019145284A1
|
|
Process for forming an organized network of semi-conducting nanoparticles or nanowires onto a silicon substrate
|
|
WO2019122340A1
|
|
In vitro method for predicting a predisposition to acute coronary syndrome
|
|
FR3088727A1
|
|
Optical device for detecting volatile compounds or adsorbable gas and associated method for detecting and quantifying volatile compounds
|
|
US2020276268A1
|
|
Fgf10 for the treatment of heart diseases
|
|
WO2019063580A1
|
|
Human soluble cd146 proteins, preparation and uses thereof
|
|
WO2019016396A1
|
|
Methods and kits for predicting the sensitivity of a subject suffering of renal cancer to sunitinib
|
|
FR3084158A1
|
|
OPTICAL FILTER CHARACTERIZATION METHOD AND DEVICE
|
|
FR3080293A1
|
|
MAGNETIC TRANSMISSION DEVICE FOR NON-INVASIVE BRAIN MAGNETIC STIMULATION AND METHOD OF USING SAME
|
|
KR20190142327A
|
|
Nanoimprint Lithography Process and Patterned Substrate Obtainable from the
|
|
WO2018154034A1
|
|
Radiolabeled soluble cd146, preparation and uses thereof
|
|
EP3502659A1
|
|
Permeametry in rarefied gas environment for characterising a multilayer porous structure
|
|
EP3502665A1
|
|
Devices and methods for total internal reflection (tir) microscopy
|
